Literature DB >> 20077432

Improving anticancer activities of Oplopanax horridus root bark extract by removing water-soluble components.

Shi Sun1, Xiao-Li Li, Chong-Zhi Wang, Stainley Williams, Chun-Su Yuan.   

Abstract

O. horridus is used as a folk medicine by natives in the Northern Pacific coast of North America. This experiment studied the antiproliferative effects of the extract of O. horridus root bark and its fractions chromatographed from Dianion HP20 resin column with water, 30, 50, 70 and 100% ethanol on human breast cancer MCF-7 cells and non-small cell lung cancer (NSCLC) cells. The role of O. horridus in the cell cycle and apoptosis of MCF-7 cells was also investigated. The results showed that the 70% and 100% ethanol fractions demonstrated more potent antiproliferative effects than the total extract on both cell lines. The antiproliferative effects may result from the enrichment of active constituents detected by high performance liquid chromatography (HPLC). The IC(50) of the total extract, 50, 70, and 100% ethanol fractions for antiproliferation on MCF-7 cells were 248.4, 123.1, 44.0, and 31.5 microg/mL, respectively, and on NSCLC cells were 125.3, 271.1, 17.6, and 23.2 microg/mL, respectively. On the other hand, the water and 30% ethanol fractions significantly promoted cell proliferation on MCF-7 cells at concentrations > 100 microg/mL, suggesting that the hydrophilic fractions should be removed from the extract when used for cancer chemoprevention in order to achieve desirable activities. The effects of the total extract on cell cycle and apoptosis were similar to that of the 100% ethanol fraction because of the similarity of their chemical composition. At higher concentrations, the apoptotic effects of the 70% ethanol fraction are more significant. Data from this study suggested that the 70% and 100% ethanol fractions are active antiproliferative fractions and that induction of apoptosis is the mechanism involved in the antiproliferative effect observed. Copyright (c) 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20077432      PMCID: PMC3057089          DOI: 10.1002/ptr.3061

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  23 in total

1.  [Phylogenetic relationships of the Far Eastern Araliaceae inferred from ITS sequences of nuclear rDNA].

Authors:  E V Artiukova; A A Goncharov; M M Kozyrenko; G D Reunova; Iu N Zhuravlev
Journal:  Genetika       Date:  2005-06

2.  Counter-current chromatography based analysis of synergy in an anti-tuberculosis ethnobotanical.

Authors:  Taichi Inui; Yuehong Wang; Shixin Deng; David C Smith; Scott G Franzblau; Guido F Pauli
Journal:  J Chromatogr A       Date:  2007-02-04       Impact factor: 4.759

Review 3.  Apoptosis in cancer.

Authors:  S W Lowe; A W Lin
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

4.  Arctic pharmacognosia II. Devil's Club, Oplopanax horridus.

Authors:  G W Smith
Journal:  J Ethnopharmacol       Date:  1983-05       Impact factor: 4.360

5.  Molecular aspects of the mammalian cell cycle and cancer.

Authors:  T Sandal
Journal:  Oncologist       Date:  2002

6.  Potential role of ginseng in the treatment of colorectal cancer.

Authors:  Chong-Zhi Wang; Chun-Su Yuan
Journal:  Am J Chin Med       Date:  2008       Impact factor: 4.667

7.  Panaxydol inhibits the proliferation and induces the differentiation of human hepatocarcinoma cell line HepG2.

Authors:  Lingchen Guo; Li Song; Zejian Wang; Wenjuan Zhao; Wenwei Mao; Ming Yin
Journal:  Chem Biol Interact       Date:  2009-05-18       Impact factor: 5.192

8.  Total saponins of Panax ginseng induces K562 cell differentiation by promoting internalization of the erythropoietin receptor.

Authors:  Guowei Zuo; Tao Guan; Dilong Chen; Chunli Li; Rong Jiang; Chunyan Luo; Xiaoshu Hu; Yaping Wang; Jianwei Wang
Journal:  Am J Chin Med       Date:  2009       Impact factor: 4.667

9.  Gitksan medicinal plants--cultural choice and efficacy.

Authors:  Leslie Main Johnson
Journal:  J Ethnobiol Ethnomed       Date:  2006-06-21       Impact factor: 2.733

10.  Antiviral screening of British Columbian medicinal plants.

Authors:  A R McCutcheon; T E Roberts; E Gibbons; S M Ellis; L A Babiuk; R E Hancock; G H Towers
Journal:  J Ethnopharmacol       Date:  1995-12-01       Impact factor: 4.360

View more
  5 in total

Review 1.  Chemical and pharmacological studies of Oplopanax horridus, a North American botanical.

Authors:  Tyler Calway; Guang-Jian Du; Chong-Zhi Wang; Wei-Hua Huang; Jing Zhao; Shao-Ping Li; Chun-Su Yuan
Journal:  J Nat Med       Date:  2011-11-20       Impact factor: 2.343

2.  Identification of potential anticancer compounds from Oplopanax horridus.

Authors:  Chong-Zhi Wang; Zhiyu Zhang; Wei-Hua Huang; Guang-Jian Du; Xiao-Dong Wen; Tyler Calway; Chunhao Yu; Rachael Nass; Jing Zhao; Wei Du; Shao-Ping Li; Chun-Su Yuan
Journal:  Phytomedicine       Date:  2013-06-05       Impact factor: 5.340

Review 3.  Bioactive C17 and C18 Acetylenic Oxylipins from Terrestrial Plants as Potential Lead Compounds for Anticancer Drug Development.

Authors:  Lars Porskjær Christensen
Journal:  Molecules       Date:  2020-05-31       Impact factor: 4.411

Review 4.  Oplopanax horridus: Phytochemistry and Pharmacological Diversity and Structure-Activity Relationship on Anticancer Effects.

Authors:  Kai Wu; Chong-Zhi Wang; Chun-Su Yuan; Wei-Hua Huang
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-13       Impact factor: 2.629

5.  Anticancer activities of polyynes from the root bark of Oplopanax horridus and their acetylated derivatives.

Authors:  Wei-Hua Huang; Li Shao; Chong-Zhi Wang; Chun-Su Yuan; Hong-Hao Zhou
Journal:  Molecules       Date:  2014-05-14       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.